2025-05-12 - Analysis Report
Okay, here's an analysis of Eli Lilly and Co (LLY) based on the data you provided, formatted as a report.

**Eli Lilly and Co (LLY) Stock Analysis**

**Company Overview:** Eli Lilly and Co is a global pharmaceutical company that develops and markets pharmaceutical products.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (LLY):** 273.60%
*   **Cumulative Return (VOO):** 87.98%
*   **Absolute Divergence:** 185.6
*   **Relative Divergence:** 58.2 (This places the current divergence in the 58.2nd percentile of its historical range relative to VOO.)

**Analysis:** LLY has significantly outperformed the S&P 500 (VOO) over the analyzed period. The relative divergence suggests that while the outperformance is substantial, it's not at the extreme upper end of its historical range.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD      | Alpha   | Beta | Cap(B) |
|------------|---------|----------|---------|------|--------|
| 2015-2017  | 14.0%   | 55.9%    | -19.0%  | 0.1  | 66.2   |
| 2016-2018  | 42.0%   | 58.6%    | 21.0%   | 0.1  | 92.9   |
| 2017-2019  | 55.0%   | 58.6%    | 21.0%   | 1.4  | 107.9  |
| 2018-2020  | 57.0%   | 58.6%    | 27.0%   | 0.7  | 141.4  |
| 2019-2021  | 116.0%  | 60.5%    | 55.0%   | 0.4  | 234.9  |
| 2020-2022  | 111.0%  | 64.9%    | 102.0%  | 0.3  | 315.3  |
| 2021-2023  | 152.0%  | 64.9%    | 132.0%  | 0.3  | 507.4  |
| 2022-2024  | 171.0%  | 72.1%    | 150.0%  | 0.3  | 676.3  |
| 2023-2025  | 105.0%  | 76.8%    | 79.0%   | 0.2  | 659.5  |

**Analysis:**

*   **CAGR:** Shows strong compound annual growth, particularly in recent periods.
*   **MDD:** Maximum Drawdown is significant, indicating considerable volatility.
*   **Alpha:** Consistently positive and high, indicating LLY has generated returns above what would be expected based on the market's performance.
*   **Beta:** Generally low, suggesting LLY is less sensitive to overall market movements than the S&P 500.
*   **Cap:** Market capitalization has grown dramatically.

**2. Recent Price Action**

*   **Current Price:** 751.45
*   **Last Market Data:** {'price': 734.57, 'previousClose': 751.45, 'change': -2.25} (close price change: -2.25%)
*   **5-Day Moving Average:** 789.67
*   **20-Day Moving Average:** 808.14
*   **60-Day Moving Average:** 832.01

**Analysis:** The current price is below all three moving averages (5, 20, and 60-day), indicating a potential short-term downtrend. The stock closed down from the previous close price. The fact that the 5-day moving average is below the 20-day moving average further strengthens this indication.

**3. Market Risk Indicators**

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 36.47 (Approaching oversold territory)
*   **PPO:** -0.98 (Negative, indicating a downtrend)
*   **Recent (20-day) Relative Divergence Change:** -4.2 (Short-term decline in relative performance)
*   **Expected Return:** 121.2% (Projected long-term outperformance vs. S&P 500)

**Analysis:** The MRI indicates low market risk. The RSI suggests the stock may be approaching oversold conditions. The negative PPO confirms the downtrend. The negative change in relative divergence aligns with the recent price weakness. The high expected return suggests analysts are optimistic about LLY's long-term prospects.

**4. Recent News & Significant Events**

*   **[2025-05-08]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-11]:** Analyst discussions on performance and outlook in relation to industry trends and global economic factors.
*   **[2025-05-10]:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **[2025-05-09]:** Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** Recent news indicates significant activity and volatility around LLY, potentially tied to business developments, regulatory changes, earnings, or executive actions. Investors should monitor these events closely.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-05-01 | 3.07  | 12.73 B$  |
| 2024-10-30 | 1.08  | 11.44 B$  |
| 2024-08-08 | 3.29  | 11.30 B$  |
| 2024-04-30 | 2.49  | 8.77 B$   |
| 2025-05-01 | 2.49  | 8.77 B$   |

**Analysis:** The table suggests strong and growing revenue and EPS numbers in recent quarters.  However, there appears to be duplicate entry for 2025-05-01. Please confirm which values are correct.
The earnings data indicates strong revenue and EPS growth, suggesting the company is performing well fundamentally.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-03-31   | $12.73B    | 82.53%        |
| 2024-12-31   | $13.53B    | 82.24%        |
| 2024-09-30   | $11.44B    | 81.02%        |
| 2024-06-30   | $11.30B    | 80.80%        |
| 2024-03-31   | $8.77B     | 80.91%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE     |
|--------------|-------------|---------|
| 2025-03-31   | $15.76B    | 17.50%  |
| 2024-12-31   | $14.19B    | 31.07%  |
| 2024-09-30   | $14.24B    | 6.81%   |
| 2024-06-30   | $13.56B    | 21.88%  |
| 2024-03-31   | $12.81B    | 17.51%  |

**Analysis:**

*   **Revenue:** Shows a generally increasing trend, indicating strong sales growth.
*   **Profit Margin:** Extremely high and relatively stable, showing efficient operations.
*   **Equity:** Growing, reflecting the company's ability to retain earnings.
*   **ROE:** Fluctuates, but generally indicates a good return on equity.  The spike in 2024-12-31 is notable.

**7. 종합적인 분석**

**Overall Assessment:**

Eli Lilly and Co (LLY) has demonstrated strong historical performance, significantly outperforming the S&P 500.  Recent price action suggests a short-term downtrend, potentially offering a buying opportunity. The company's fundamentals appear solid, with strong revenue growth, high profit margins, and a positive outlook based on analyst estimates and the MRI.

**Key Considerations:**

*   **Recent News & Volatility:** Monitor recent news and company announcements for potential impacts on the stock.
*   **Moving Averages:** Watch for a potential break above the moving averages as a sign of trend reversal.
*   **RSI:** The RSI suggests the stock may be approaching oversold conditions, which could lead to a rebound.

**Investment Recommendation:**

Based on the provided information, LLY appears to be a fundamentally strong company with good long-term prospects. However, the recent short-term downtrend and news-driven volatility warrant caution. Consider a staggered entry strategy, taking advantage of potential price weakness. Continued monitoring of news, earnings, and technical indicators is essential.
